Lilly planning diabetes facility in Shanghai

Eli Lilly and Co. (NYSE:LLY) plans to open a diabetes R&D facility in Shanghai in 2H11. The center will be led by Bei Zhang, VP of research for Lilly Research Laboratories in China, and will initially...